Efficacy and Safety of Dual Blockade of the Renin–Angiotensin–Aldosterone System in Diabetic Kidney Disease: A Meta-Analysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and Safety of Dual Blockade of the Renin–Angiotensin–Aldosterone System in Diabetic Kidney Disease: A Meta-Analysis
Authors
Keywords
-
Journal
American Journal of Cardiovascular Drugs
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-02-09
DOI
10.1007/s40256-018-00321-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Additive Therapy With Spironolactone on Proteinuria in Diabetic Patients Already on ACE Inhibitor or ARB Therapy
- (2016) Mohammad G. Saklayen et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial
- (2015) Sawako Kato et al. Clinical and Experimental Nephrology
- Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy
- (2015) George L. Bakris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis
- (2015) Suetonia C Palmer et al. LANCET
- Potassium Handling with Dual Renin-Angiotensin System Inhibition in Diabetic Nephropathy
- (2014) P. N. Van Buren et al. Clinical Journal of the American Society of Nephrology
- Mineralocorticoid Receptor Blockade Improves Coronary Microvascular Function in Individuals With Type 2 Diabetes
- (2014) Rajesh Garg et al. DIABETES
- Efficacy and Safety of Combined vs. Single Renin-Angiotensin-Aldosterone System Blockade in Chronic Kidney Disease: A Meta-Analysis
- (2013) P. Susantitaphong et al. AMERICAN JOURNAL OF HYPERTENSION
- Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease
- (2013) Regina Kunz et al. ANNALS OF INTERNAL MEDICINE
- Effects of dual blockade of the renin–angiotensin system on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy and hypertension in the ORIENT: a post-hoc analysis (ORIENT–Hypertension)
- (2013) Enyu Imai et al. HYPERTENSION RESEARCH
- 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
- (2013) Paul A. James et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
- (2013) Linda F. Fried et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Dual Blockade of the Renin-Angiotensin System on the Progression of Type 2 Diabetic Nephropathy: A Randomized Trial
- (2012) Gema Fernandez Juarez et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Spironolactone diminishes urinary albumin excretion in patients with type 1 diabetes and microalbuminuria: a randomized placebo-controlled crossover study
- (2012) S. E. Nielsen et al. DIABETIC MEDICINE
- Randomized Study of Antihypertensive Efficacy and Safety of Combination Aliskiren/Valsartan vs Valsartan Monotherapy in Hypertensive Participants With Type 2 Diabetes Mellitus
- (2012) George L. Bakris et al. Journal of Clinical Hypertension
- Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
- (2012) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combination therapy with an angiotensin-converting-enzyme inhibitor and an angiotensin II receptor antagonist ameliorates microinflammation and oxidative stress in patients with diabetic nephropathy
- (2012) Akihiko Nakamura et al. Journal of Diabetes Investigation
- ACEI and ARB combination therapy in patients with macroalbuminuric diabetic nephropathy and low socioeconomic level: a double-blind randomized clinical trial
- (2011) S.M. Titan et al. CLINICAL NEPHROLOGY
- Impact of aliskiren treatment on urinary aldosterone levels in patients with type 2 diabetes and nephropathy: an AVOID substudy
- (2011) Frederik Persson et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Of fads, fashion, surrogate endpoints and dual RAS blockade
- (2010) F. H. Messerli et al. EUROPEAN HEART JOURNAL
- Dual Blockade of the Renin-Angiotensin-Aldosterone System: Beyond the ACE Inhibitor and Angiotensin-II Receptor Blocker Combination
- (2009) A. S. Bomback et al. AMERICAN JOURNAL OF HYPERTENSION
- Managing diabetes in hemodialysis patients: Observations and recommendations
- (2009) K. SHRISHRIMAL et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- Cystatin C, Albuminuria, and Mortality Among Older Adults With Diabetes
- (2009) I. H. de Boer et al. DIABETES CARE
- Renal Effects of Aliskiren Compared With and in Combination With Irbesartan in Patients With Type 2 Diabetes, Hypertension, and Albuminuria
- (2009) F. Persson et al. DIABETES CARE
- Global estimates of the prevalence of diabetes for 2010 and 2030
- (2009) J.E. Shaw et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Valsartan in combination with lisinopril versus the respective high dose monotherapies in hypertensive patients with microalbuminuria: the VALERIA trial
- (2009) Jan Menne et al. JOURNAL OF HYPERTENSION
- Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
- (2009) U. F. Mehdi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The current state of RAAS blockade in the treatment of hypertension and proteinuria
- (2009) Rigas G. Kalaitzidis et al. Current Cardiology Reports
- Antiproteinuric Response to Dual Blockade of the Renin-Angiotensin System in Primary Glomerulonephritis: Meta-analysis and Metaregression
- (2008) Fausta Catapano et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Is There Added Value to Adding ARB to ACE Inhibitors in the Management of CKD?
- (2008) D. L. Cohen et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
- (2008) Johannes FE Mann et al. LANCET
- Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
- (2008) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started